Abstract:Topical photodynamic therapy (PDT) is widely accepted as an effective treatment for superficial basal cell carcinoma (sBCC). As with other nonsurgical approaches, clearance and recurrence rates are higher following PDT than definitive surgical excision, with overall clearance at 1 year of approximately 76% being expected. For many patients this is a very suitable treatment approach, particularly if lesions are large and/or multiple, or the patient is not suitable for surgery because of co-morbidities. However, optimizing PDT outcomes through exploration of variables in treatment parameters, such as drug and light delivery, is a priority. In this issue of the BJD, Kessels and colleagues report on a randomized controlled trial in which topical aminolaevulinic acid (ALA) PDT using a fractionated irradiation regimen with a 2-h dark interval delivered on 1 day was compared with conventional methyl aminolaevulinate (MAL) PDT given as two treatments 1 week apart for sBCC. This research group has previously undertaken preclinical and clinical studies, indicating that high clearance rates can be achieved using this fractionated ALA PDT regimen. The two-fold irradiation process resulted in superior clearance rates of sBCC compared with a single continuous irradiation when followed up to 5 years after treatment, supporting previous preclinical study observations. The hypothesis is that increased efficiency of PDT may be achieved due to optimizing reoxygenation during the dark interval and through an enhanced immune response. In the current study, while there was a suggestion of higher clearance rates of sBCC 1 year after the fractionated ALA PDT regimen compared with the MAL PDT regimen, this was a nonsignificant result, possibly due to the sample size and power of the study. Indeed, the fractionated ALA PDT regimen resulted in greater side-effects, notably pain. The study arms had several variables of prodrugs, application time of prodrugs, light sources and irradiation regimens. Therefore, given also that the differences in efficacy were nonsignificant, it is difficult to draw firm conclusions regarding the actual impact of the fractionation of irradiation per se. The study was well undertaken in robust format and, building on the authors’ track record from earlier studies, together indicates that a fractionated ALA PDT regimen undertaken within the same day is an option for effective treatment of sBCC, although patients need to be advised of the risk of higher pain levels. It would be most interesting to compare ALA PDT with MAL PDT both with fractionated irradiation as the only variable in a larger sample size. This is an important contribution to the literature as it highlights that there may be many ways to optimally deliver effective PDT. Clinic arrangements and patient preference regarding acceptance of risk of discomfort with treatment and whether it is preferred to have treatment all in one longer day or to return for a second treatment at 1 week are factors to take into account. While effective, we cannot conclusively say that there is a conferred advantage of a fractionated regimen for effective clearance of sBCC and it may be at the trade-off of increased side-effects. However, having options regarding how to deliver effective PDT is key and this certainly warrants further study.

Ixekizumab or secukinumab in psoriasis: what difference does it make?

Predicting Fault-Prone Modules: A Comparative Study

Efficacy and safety of 1C class antiarrhythmic agent (propafenone) for supraventricular arrhythmias in septic shock compared to amiodarone: protocol of a prospective randomised double-blind study

Echocardiography predictors of sustained sinus rhythm after cardioversion of supraventricular arrhythmia in patients with septic shock

Achieving pregnancy against the odds: successful implantation of frozen-thawed embryos generated by ICSI using spermatozoa banked prior to chemo/radiotherapy for Hodgkin's disease and acute leukaemia.

Vasoactive Agents for the Treatment of Sepsis.

Short-term and long-term outcomes of cardiac arrhythmias in patients with cardiogenic shock

The outcomes of patients with septic shock treated with propafenone compared to amiodarone for supraventricular arrhythmias are related to end-systolic left atrial volume

Ivabradine in Septic Shock: A Narrative Review

Update on management of cardiac arrhythmias in acute coronary syndromes

Pharmacotherapy in Ventricular Arrhythmias

[Heart Rate Control in Patients with Sepsis and Septic Cardiomyopathy: the Role of Ivabradine].

Pharmacological cardioversion of atrial fibrillation: current management and treatment options

A Cost Effective Method for Matching the 3D Motion Trajectories

Effectiveness of Anisodamine for the Treatment of Critically Ill Patients with Septic Shock (acidosis Study): Study Protocol for Randomized Controlled Trial

The autonomic nervous system in septic shock and its role as a future therapeutic target: a narrative review

Central Venous-To-Arterial Carbon Dioxide Partial Pressure Difference As A Guiding Parameter For Cardiotonic Drug Administration In Patients With Early-Stage Septic Shock

Sepsis and septic shock: pathophysiological and cardiovascular background as basis for therapy

Vasoactive pharmacologic therapy in cardiogenic shock: a critical review

Practical Considerations in Sepsis Resuscitation

Management of ventricular tachycardia in patients with ischaemic cardiomyopathy: contemporary armamentarium